The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Metabolomics and Type 2 Diabetes Risk: An Updated Systematic Review and Meta-analysis of Prospective Cohort Studies
Open accessAbstract
BACKGROUND: Due to the rapidly increasing availability of metabolomics data in prospective studies, an update of the meta evidence on metabolomics and type 2 diabetes risk is warranted. PURPOSE: To conduct an updated systematic review and meta-analysis of plasma, serum, and urine metabolite markers and incident type 2 diabetes. DATA SOURCES: We searched PubMed and Embase until 6 March 2021. STUDY SELECTION: We selected prospective observational studies where investigators used high-throughput techniques to investigate the relationship between plasma, serum, or urine metabolites and incident type 2 diabetes. DATA EXTRACTION: Baseline metabolites per-SD risk estimates and 95% CIs for incident type 2 diabetes were extracted from all eligible studies. DATA SYNTHESIS: A total of 61 reports with 71,196 participants and 11,771 type 2 diabetes cases/events were included in the updated review. Meta-analysis was performed for 412 metabolites, of which 123 were statistically significantly associated (false discovery rate–corrected P < 0.05) with type 2 diabetes risk. Higher plasma and serum levels of certain amino acids (branched-chain, aromatic, alanine, glutamate, lysine, and methionine), carbohydrates and energy-related metabolites (mannose, trehalose, and pyruvate), acylcarnitines (C4-DC, C4-OH, C5, C5-OH, and C8:1), the majority of glycerolipids (di- and triacylglycerols), (lyso)phosphatidylethanolamines, and ceramides included in meta-analysis were associated with higher risk of type 2 diabetes (hazard ratio 1.07–2.58). Higher levels of glycine, glutamine, betaine, indolepropionate, and (lyso)phosphatidylcholines were associated with lower type 2 diabetes risk (hazard ratio 0.69–0.90). LIMITATIONS: Substantial heterogeneity (I2 > 50%, τ2 > 0.1) was observed for some of the metabolites. CONCLUSIONS: Several plasma and serum metabolites, including amino acids, lipids, and carbohydrates, are associated with type 2 diabetes risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Cochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
Metabolite profiles and the risk of developing diabetes
Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143
Evaluation of the Quality of Prognosis Studies in Systematic Reviews
Hayden, J. A., Côté, P., & Bombardier, C. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-6-200603210-00010 · Cited by 1,452
Metabolomics for Investigating Physiological and Pathophysiological Processes
Wishart, D. S. (2019) · Physiological Reviews · doi:10.1152/physrev.00035.2018 · Cited by 1,212
A comparison of heterogeneity variance estimators in simulated random‐effects meta‐analyses
Langan, D., Higgins, J. P. T., Jackson, D., Bowden, J., Veroniki, A. A., Kontopantelis, E., Viechtbauer, W., & Simmonds, M. (2019) · Research Synthesis Methods · doi:10.1002/jrsm.1316 · Cited by 1,074
Floegel, A., Stefan, N., Yu, Z., Mühlenbruch, K., Drogan, D., Joost, H.-G., Fritsche, A., Häring, H.-U., Hrabě de Angelis, M., Peters, A., et al. (2013) · Diabetes · doi:10.2337/db12-0495 · Cited by 988
Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis
Guasch-Ferré, M., Hruby, A., Toledo, E., Clish, C. B., Martínez-González, M. A., Salas-Salvadó, J., & Hu, F. B. (2016) · Diabetes Care · doi:10.2337/dc15-2251 · Cited by 905
Self-citationTurner, R. M., Davey, J., Clarke, M. J., Thompson, S. G., & Higgins, J. P. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys041 · Cited by 837
Novel biomarkers for pre-diabetes identified by metabolomics
Wang‐Sattler, R., Yu, Z., Herder, C., Messias, A. C., Floegel, A., He, Y., Heim, K., Campillos, M., Holzapfel, C., Thorand, B., et al. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.43 · Cited by 701
Rhee, E. P., Cheng, S., Larson, M. G., Walford, G. A., Lewis, G. D., McCabe, E., Yang, E., Farrell, L., Fox, C. S., O’Donnell, C. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44442 · Cited by 647
Schooneman, M. G., Vaz, F. M., Houten, S. M., & Soeters, M. R. (2013) · Diabetes · doi:10.2337/db12-0466 · Cited by 616
Metabolite Profiling Identifies Pathways Associated With Metabolic Risk in Humans
Cheng, S., Rhee, E. P., Larson, M. G., Lewis, G. D., McCabe, E. L., Shen, D., Palma, M. J., Roberts, L. D., Dejam, A., Souza, A. L., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.067827 · Cited by 587
2-Aminoadipic acid is a biomarker for diabetes risk
Wang, T. J., Ngo, D., Psychogios, N., Dejam, A., Larson, M. G., Vasan, R. S., Ghorbani, A., O’Sullivan, J., Cheng, S., Rhee, E. P., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64801 · Cited by 452
The Emerging Role of Branched-Chain Amino Acids in Insulin Resistance and Metabolism
Yoon, M.-S. (2016) · Nutrients · doi:10.3390/nu8070405 · Cited by 430
Lotta, L. A., Scott, R. A., Sharp, S. J., Burgess, S., Luan, J., Tillin, T., Schmidt, A. F., Imamura, F., Stewart, I. D., Perry, J. R. B., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002179 · Cited by 417 · cited 2×
“BCAAs were the first and, so far, the most widely investigated group of metabolites in the context of type 2 diabetes development (27,65).”
Backgroundde Mello, V. D., Paananen, J., Lindström, J., Lankinen, M. A., Shi, L., Kuusisto, J., Pihlajamäki, J., Auriola, S., Lehtonen, M., Rolandsson, O., et al. (2017) · Scientific Reports · doi:10.1038/srep46337 · Cited by 379
Ferrannini, E., Natali, A., Camastra, S., Nannipieri, M., Mari, A., Adam, K.-P., Milburn, M. V., Kastenmüller, G., Adamski, J., Tuomi, T., et al. (2013) · Diabetes · doi:10.2337/db12-0707 · Cited by 349
Palmer, N. D., Stevens, R. D., Antinozzi, P. A., Anderson, A., Bergman, R. N., Wagenknecht, L. E., Newgard, C. B., & Bowden, D. W. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2357 · Cited by 253
Reproducibility of Metabolomic Profiles among Men and Women in 2 Large Cohort Studies
Townsend, M. K., Clish, C. B., Kraft, P., Wu, C., Souza, A. L., Deik, A. A., Tworoger, S. S., & Wolpin, B. M. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.199133 · Cited by 242
Tillin, T., Hughes, A. D., Wang, Q., Würtz, P., Ala-Korpela, M., Sattar, N., Forouhi, N. G., Godsland, I. F., Eastwood, S. V., McKeigue, P. M., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3517-8 · Cited by 227
Ahola-Olli, A. V., Mustelin, L., Kalimeri, M., Kettunen, J., Jokelainen, J., Auvinen, J., Puukka, K., Havulinna, A. S., Lehtimäki, T., Kähönen, M., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-05001-w · Cited by 214
Mechanisms of Increased In Vivo Insulin Sensitivity by Dietary Methionine Restriction in Mice
Stone, K. P., Wanders, D., Orgeron, M., Cortez, C. C., & Gettys, T. W. (2014) · Diabetes · doi:10.2337/db14-0464 · Cited by 200
Branched-chain and aromatic amino acid profiles and diabetes risk in Chinese populations
Chen, T., Ni, Y., Ma, X., Bao, Y., Liu, J., Huang, F., Hu, C., Xie, G., Zhao, A., Jia, W., et al. (2016) · Scientific Reports · doi:10.1038/srep20594 · Cited by 200
Raichur, S., Brunner, B., Bielohuby, M., Hansen, G., Pfenninger, A., Wang, B., Bruning, J. C., Larsen, P. J., & Tennagels, N. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2018.12.008 · Cited by 192
Vangipurapu, J., Stancáková, A., Smith, U., Kuusisto, J., & Laakso, M. (2019) · Diabetes · doi:10.2337/db18-1076 · Cited by 185
Wang, Q., Holmes, M. V., Davey Smith, G., & Ala-Korpela, M. (2017) · Diabetes Care · doi:10.2337/dc17-1642 · Cited by 182
Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence
Chew, W. S., Torta, F. T., Ji, S., Choi, H., Begum, H., Sim, X., Khoo, C. M., Khoo, E. Y. H., Ong, W., van Dam, R. M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126925 · Cited by 166
Early Prediction of Developing Type 2 Diabetes by Plasma Acylcarnitines: A Population-Based Study
Sun, L., Liang, L., Gao, X., Zhang, H., Yao, P., Hu, Y., Ma, Y., Wang, F., Jin, Q., Li, H., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0232 · Cited by 164
Self-citationMahendran, Y., Cederberg, H., Vangipurapu, J., Kangas, A. J., Soininen, P., Kuusisto, J., Uusitupa, M., Ala-Korpela, M., & Laakso, M. (2013) · Diabetes Care · doi:10.2337/dc13-0800 · Cited by 162
Lu, Y., Wang, Y., Ong, C.-N., Subramaniam, T., Choi, H. W., Yuan, J.-M., Koh, W.-P., & Pan, A. (2016) · Diabetologia · doi:10.1007/s00125-016-4069-2 · Cited by 158
Merino, J., Leong, A., Liu, C., Porneala, B., Walford, G. A., von Grotthuss, M., Wang, T. J., Flannick, J. A., Dupuis, J., Levy, D. A., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4599-x · Cited by 156
Early metabolic markers identify potential targets for the prevention of type 2 diabetes
Gopalacharyulu, P. V., Cobb, J. E., Yengo, L., Froguel, P., Kravić, J., Balkau, B., Tuomilehto, J., Aittokallio, T. A., & Groop, L. (2017) · Diabetologia · doi:10.1007/s00125-017-4325-0 · Cited by 154
Microbiota-Related Metabolites and the Risk of Type 2 Diabetes
Vangipurapu, J., Silva, L. F., Kuulasmaa, T., Smith, U., & Laakso, M. (2020) · Diabetes Care · doi:10.2337/dc19-2533 · Cited by 151
Drogan, D., Dunn, W. B., Lin, W., Buijsse, B., Schulze, M. B., Langenberg, C., Brown, M., Floegel, A., Dietrich, S., Rolandsson, O., et al. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.228965 · Cited by 150
Carayol, M., Licaj, I., Achaintre, D., Sacerdote, C., Vineis, P., Key, T. J., Onland‐Moret, N. C., Scalbert, A., Rinaldi, S., & Ferrari, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135437 · Cited by 148
Lu, J., Lam, S. M., Wan, Q., Shi, L., Huo, Y., Chen, L., Tang, X., Li, B., Wu, X., Peng, K., et al. (2019) · Diabetes Care · doi:10.2337/dc19-0100 · Cited by 148
Branched-chain amino acids as biomarkers in diabetes
Giesbertz, P., & Daniel, H. (2015) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000235 · Cited by 133
Guasch‐Ferré, M., Santos, J. L., Martínez‐González, M. Á., Clish, C. B., Razquín, C., Wang, D., Liang, L., Li, J., Dennis, C., Corella, D., et al. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa016 · Cited by 131
Self-citationSerum metabolomic profile of incident diabetes
Rebholz, C. M., Yu, B., Zheng, Z., Chang, P., Tin, A., Köttgen, A., Wagenknecht, L. E., Coresh, J., Boerwinkle, E., & Selvin, E. (2018) · Diabetologia · doi:10.1007/s00125-018-4573-7 · Cited by 129
Association of Ketone Body Levels With Hyperglycemia and Type 2 Diabetes in 9,398 Finnish Men
Mahendran, Y., Vangipurapu, J., Cederberg, H., Stančáková, A., Pihlajamäki, J., Soininen, P., Kangas, A. J., Paananen, J., Civelek, M., Saleem, N. K., et al. (2013) · Diabetes · doi:10.2337/db12-1363 · Cited by 127
Liu, X., Zheng, Y., Guasch‐Ferré, M., Ruiz‐Canela, M., Toledo, E., Clish, C. B., Liang, L., Razquín, C., Corella, D., Estruch, R., et al. (2019) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2019.06.005 · Cited by 121
Self-citationFall, T., Salihović, S., Brandmaier, S., Nowak, C., Ganna, A., Gustafsson, S., Broeckling, C. D., Prenni, J. E., Kastenmüller, G., Peters, A., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-4041-1 · Cited by 112
The Consortium of Metabolomics Studies (COMETS): Metabolomics in 47 Prospective Cohort Studies
Yu, B., Zanetti, K. A., Temprosa, M. G., Albanes, D., Appel, N., Barrios-Barrera, C., Ben‐Shlomo, Y., Boerwinkle, E., Casas, J. P., Clish, C. B., et al. (2019) · American Journal of Epidemiology · doi:10.1093/aje/kwz028 · Cited by 112
Altered Asparagine and Glutamate Homeostasis Precede Coronary Artery Disease and Type 2 Diabetes
Ottosson, F. A., Smith, E., Melander, O., & Fernandez, C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00546 · Cited by 107
Yu, E., Papandreou, C., Ruiz‐Canela, M., Guasch‐Ferré, M., Clish, C. B., Dennis, C., Liang, L., Corella, D., Fitó, M., Razquín, C., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.288720 · Cited by 106
Self-citationYun, H., Sun, L. T., Wu, Q., Zong, G., Qi, Q., Li, H., Zheng, H., Zeng, R., Liang, L., & Lin, X. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003451 · Cited by 106
Liu, X., Hoene, M., Wang, X., Yin, P., Häring, H., Xu, G., & Lehmann, R. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.03.009 · Cited by 104
Metabolomics based markers predict type 2 diabetes in a 14-year follow-up study
Liu, J., Semiz, S., van der Lee, S. J., van der Spek, A., Verhoeven, A., van Klinken, J. B., Sijbrands, E. J. G., Harms, A. C., Hankemeier, T., van Dijk, K. W., et al. (2017) · Metabolomics · doi:10.1007/s11306-017-1239-2 · Cited by 101
Guasch‐Ferré, M., Ruiz‐Canela, M., Li, J., Zheng, Y., Bulló, M., Wang, D. D., Toledo, E., Clish, C. B., Corella, D., Estruch, R., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01000 · Cited by 100
Self-citationProspective Associations of Systemic and Urinary Choline Metabolites with Incident Type 2 Diabetes
Svingen, G. F. T., Schartum-Hansen, H., Pedersen, E. R., Ueland, P. M., Tell, G. S., Mellgren, G., Njølstad, P. R., Seifert, R., Strand, E., Karlsson, T. R., et al. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.250761 · Cited by 94
Qiu, G., Zheng, Y., Wang, H., Sun, J., Ma, H., Xiao, Y., Li, Y., Yuan, Y. L., Yang, H., Li, X., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw221 · Cited by 92
Self-citationNovel Metabolic Markers for the Risk of Diabetes Development in American Indians
Zhao, J., Zhu, Y., Hyun, N., Zeng, D., Uppal, K., Tran, V., Yu, T., Jones, D. P., He, J., Lee, E. T., et al. (2014) · Diabetes Care · doi:10.2337/dc14-2033 · Cited by 80
Yu, D., Moore, S. C., Matthews, C. E., Xiang, Y., Zhang, X., Gao, Y., Zheng, W., & Shu, X. (2015) · Metabolomics · doi:10.1007/s11306-015-0890-8 · Cited by 80
Shi, L. S., Brunius, C. F., Lehtonen, M., Auriola, S. O. K., Bergdahl, I. A., Rolandsson, O., Hanhineva, K., & Landberg, R. (2018) · Diabetologia · doi:10.1007/s00125-017-4521-y · Cited by 80
Yang, S. J., Kwak, S., Jo, G., Song, T., & Shin, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-26320-9 · Cited by 71
2-Aminoadipic acid (2-AAA) as a potential biomarker for insulin resistance in childhood obesity
Lee, H., Jang, H. B., Kim, W., Park, K. J., Kim, K. Y., Park, S. I., & Lee, H. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-49578-z · Cited by 70
Papandreou, C., Bulló, M., Zheng, Y., Ruiz‐Canela, M., Yu, E., Guasch‐Ferré, M., Toledo, E., Clish, C. B., Corella, D., Estruch, R., et al. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy058 · Cited by 66
Self-citationRazquín, C., Ruiz‐Canela, M., Clish, C. B., Li, J., Toledo, E., Dennis, C., Liang, L., Salas‐Huetos, A., Pierce, K. A., Guasch‐Ferré, M., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0958-2 · Cited by 64
Self-citationMamtani, M., Kulkarni, H. R., Wong, G., Weir, J. M., Barlow, C. K., Dyer, T. D., Almasy, L. A., Mahaney, M. C., Comuzzie, A. G., Glahn, D. C., et al. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0234-3 · Cited by 63
Fizelova, M., Miilunpohja, M., Kangas, A. J., Soininen, P., Kuusisto, J., Ala‐Korpela, M., Laakso, M., & Stančáková, A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.03.034 · Cited by 55
Savolainen, O. I., Lind, M. V., Bergström, G. M. L., Fagerberg, B., Sandberg, A., & Ross, A. B. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.152850 · Cited by 54
Metabolomic Signatures of Long-term Coffee Consumption and Risk of Type 2 Diabetes in Women
Hang, D., Zeleznik, O. A., He, X., Guasch‐Ferré, M., Jiang, X., Li, J., Liang, L., Eliassen, A. H., Clish, C. B., Chan, A. T., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0800 · Cited by 54
Self-citationFernandez, C., Surma, M. A., Klose, C. D., Gerl, M. J., Ottosson, F. A., Ericson, U., Oskolkov, N., Ohro-Melander, M., Simons, K., & Melander, O. (2019) · Diabetes Care · doi:10.2337/dc19-1199 · Cited by 50
Chen, G., Chai, J. C., Yu, B., Michelotti, G. A., Grove, M. L., Fretts, A. M., Daviglus, M. L., Garcia‐Bedoya, O., Thyagarajan, B., Schneiderman, N., et al. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa114 · Cited by 46
Shi, L. S., Brunius, C. F., Johansson, I., Bergdahl, I. A., Lindahl, B., Hanhineva, K., & Landberg, R. (2018) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy145 · Cited by 44
Serum Amino Acids in Association with Prevalent and Incident Type 2 Diabetes in A Chinese Population
Lu, Y., Wang, Y., Xu, L., Zou, L., Ong, C. N., Yuan, J., Koh, W., & Pan, A. (2019) · Metabolites · doi:10.3390/metabo9010014 · Cited by 44
Ottosson, F. A., Smith, E., Gallo, W., Fernandez, C., & Melander, O. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00822 · Cited by 43
Shi, L. S., Brunius, C. F., Johansson, I., Bergdahl, I. A., Rolandsson, O., Guelpen, B. R. V., Winkvist, A., Hanhineva, K., & Landberg, R. (2019) · Journal of Internal Medicine · doi:10.1111/joim.13009 · Cited by 43
Serum acylcarnitines and amino acids and risk of type 2 diabetes in a multiethnic Asian population
Gunther, S. H., Khoo, C. M., Tai, E. S., Sim, X., Kovalik, J., Ching, J., Lee, J. J., & van Dam, R. M. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001315 · Cited by 43
Strand, E., Rebnord, E. W., Flygel, M. R., Lysne, V., Svingen, G. F. T., Tell, G. S., Løland, K. H., Berge, R. K., Svardal, A. M., Nygard, O. K., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02139 · Cited by 38
Serum Lipids in Association With Type 2 Diabetes Risk and Prevalence in a Chinese Population
Lu, Y., Wang, Y., Zou, L., Xu, L., Ong, C. N., Subramaniam, T., Yuan, J., Koh, W., & Pan, A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02176 · Cited by 35
Muilwijk, M., Goorden, S. M. I., Celis-Morales, C. A., Hof, M. H. P., der Vlugt, K. G., Stet, F. S., Gill, J. M. R., Vaz, F. M., & van Valkengoed, I. G. M. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001003 · Cited by 29
Chen, Z., Liu, J., Morningstar, J. E., Heckman‐Stoddard, B. M., Lee, C. G., Dagogo-Jack, S. E., Ferguson, J. F., Hamman, R. F., Knowler, W. C., Mather, K. J., et al. (2019) · Diabetes · doi:10.2337/db19-0236 · Cited by 28
Yu, E., Ruiz‐Canela, M., Razquín, C., Guasch‐Ferré, M., Toledo, E., Wang, D. D., Papandreou, C., Dennis, C., Clish, C. B., Liang, L., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13514 · Cited by 26
Self-citationGängler, S., Waldenberger, M., Artati, A., Adamski, J., van Bolhuis, J. N., Sørgjerd, E. P., van Vliet‐Ostaptchouk, J. V., & Makris, K. C. (2019) · Metabolomics · doi:10.1007/s11306-019-1519-0 · Cited by 25
Noerman, S., Kärkkäinen, O. K., Mattsson, A., Paananen, J., Lehtonen, M., Nurmi, T., Tuomainen, T., Voutilainen, S., Hanhineva, K., & Virtanen, J. K. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800605 · Cited by 22
Friedrich, N., Budde, K., Suhre, K., Völker, U., John, U., Felix, S. B., Kroemer, H. K., Grabe, H. J., Völzke, H., Nauck, M. A., et al. (2015) · Metabolomics · doi:10.1007/s11306-015-0795-6 · Cited by 21
Shi, L. S., Brunius, C. F., Bergdahl, I. A., Johansson, I., Rolandsson, O., Donat‐Vargas, C., Kiviranta, H., Hanhineva, K., Åkesson, A., & Landberg, R. (2019) · Journal of Nutrition · doi:10.1093/jn/nxz068 · Cited by 18
Rahman, F., Blumenthal, R. S., Jones, S. R., Martin, S. S., Gluckman, T. J., & Whelton, S. P. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0713-2 · Cited by 16
Cited by
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A. Z., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,080
Diabetes mellitus—Progress and opportunities in the evolving epidemic
Abel, E. D., Gloyn, A. L., Evans-Molina, C., Joseph, J. J., Misra, S., Pajvani, U. B., Simcox, J., Susztak, K., & Drucker, D. J. (2024) · Cell · doi:10.1016/j.cell.2024.06.029 · Cited by 292
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus
Xourafa, G., Korbmacher, M., & Roden, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00898-1 · Cited by 274
Individual variations in glycemic responses to carbohydrates and underlying metabolic physiology
Wu, Y., Ehlert, B., Metwally, A. A., Perelman, D., Park, H., Brooks, A. W., Abbasi, F., Michael, B., Celli, A., Bejikian, C., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03719-2 · Cited by 48
Metadata
- Authors
- Morze, J., Wittenbecher, C., Schwingshackl, L., Danielewicz, A., Rynkiewicz, A., Hu, F. B., & Guasch-Ferré, M.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2022-03-29
- Volume
- 45
- Issue
- 4
- Pages
- 1013-1024
- ISSN
- 0149-5992 (ISSN-L)
- OpenAlex
- W4225413474
- Cited by
- 298
- References
- 81
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.